Edwards Lifesciences (EW) Goodwill (2009 - 2026)

Edwards Lifesciences has reported Goodwill for 18 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Goodwill rose 9.82% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 9.82% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, changed 0.46% from the prior year.
• Goodwill was $2.0 billion for Q2 2026 at Edwards Lifesciences, up from $1.8 billion in the prior quarter.
• The five-year high for Goodwill was $2.0 billion in Q2 2026, with the low at $1.1 billion in Q4 2022.
• Average Goodwill over 5 years is $1.5 billion, with a median of $1.3 billion recorded in 2023.
• The largest YoY upside for Goodwill was 55.16% in 2024 against a maximum downside of 11.43% in 2024.
• Over 5 years, Goodwill stood at $1.1 billion in 2022, then grew by 7.54% to $1.1 billion in 2023, then soared by 55.16% to $1.8 billion in 2024, then retreated by 0.46% to $1.8 billion in 2025, then increased by 10.32% to $2.0 billion in 2026.
• The last three Goodwill figures came in at $2.0 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.